Suppr超能文献

胆管癌:解剖学位置相关的临床、预后及基因差异

Cholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparities.

作者信息

Hang Hualian, Jeong Seogsong, Sha Meng, Kong Defu, Xi Zhifeng, Tong Ying, Xia Qiang

机构信息

Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

出版信息

Ann Transl Med. 2019 Dec;7(23):744. doi: 10.21037/atm.2019.12.37.

Abstract

BACKGROUND

Anatomical location is considered in diagnostic and therapeutic approaches of cholangiocarcinoma (CCA). However, disparities and its extents in proportion of surgical candidates, prognostic factors, prognostic genetic networks, susceptibility for lymph node dissection, and disease stage at diagnosis remain to be confirmed.

METHODS

A total of 11,710 patients with cholangiocarcinoma from Surveillance, Epidemiology, and End Results Cancer Registries (SEER) and 45 CCA patients with paired tumor and normal specimens from The Cancer Genome Atlas were studied. Kaplan-Meier estimation, Cox proportional hazards regression, Pearson's correlation, comparison between anatomical location (distal, intrahepatic, and perihilar)-dependent CCAs, differential expressive gene stratification, potential interactive gene identification, and confirmation on pathways of the prognostic networks were carried out.

RESULTS

Survival outcomes were most favorable in the distal type, followed by perihilar and intrahepatic types, but postsurgical prognosis was slightly higher in intrahepatic type compared to perihilar type. Distant historic stage at diagnosis was noticed in intrahepatic type. Significant prognostic factors and their hazards ratios were dependent to the anatomical location. In addition, lymph node dissection provided significant survival benefits in perihilar type only. Furthermore, prognosis-predictive genes, as well as potential processes and pathways, were significantly among the anatomical location-dependent types that the genes barely overlapped.

CONCLUSIONS

There are disparities in almost all aspects among distal, intrahepatic, and perihilar CCAs. Anatomical location needs to be considered in treatment, prognostic estimation, identifying targets, and developing therapeutic approaches for CCA.

摘要

背景

在胆管癌(CCA)的诊断和治疗方法中会考虑解剖位置。然而,在手术候选者比例、预后因素、预后遗传网络、淋巴结清扫易感性以及诊断时的疾病分期方面的差异及其程度仍有待确定。

方法

对监测、流行病学和最终结果癌症登记处(SEER)的11710例胆管癌患者以及来自癌症基因组图谱的45例配对肿瘤和正常标本的CCA患者进行了研究。进行了Kaplan-Meier估计、Cox比例风险回归、Pearson相关性分析、不同解剖位置(远端、肝内和肝门周围)依赖性CCA之间的比较、差异表达基因分层、潜在相互作用基因鉴定以及对预后网络途径的确认。

结果

生存结果在远端型中最为有利,其次是肝门周围型和肝内型,但肝内型手术后的预后略高于肝门周围型。肝内型在诊断时远处历史分期较高。显著的预后因素及其风险比取决于解剖位置。此外,淋巴结清扫仅在肝门周围型中提供了显著的生存益处。此外,预后预测基因以及潜在的过程和途径在解剖位置依赖性类型之间存在显著差异,这些基因几乎没有重叠。

结论

远端、肝内和肝门周围CCA在几乎所有方面都存在差异。在CCA的治疗、预后评估、确定靶点和开发治疗方法时需要考虑解剖位置。

相似文献

1
Cholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparities.
Ann Transl Med. 2019 Dec;7(23):744. doi: 10.21037/atm.2019.12.37.
3
Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma.
Front Oncol. 2021 Sep 29;11:757498. doi: 10.3389/fonc.2021.757498. eCollection 2021.
4
The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Eur J Surg Oncol. 2019 Aug;45(8):1468-1478. doi: 10.1016/j.ejso.2019.04.019. Epub 2019 Apr 25.
5
Pathologic classification of cholangiocarcinoma: New concepts.
Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):277-93. doi: 10.1016/j.bpg.2015.02.006. Epub 2015 Feb 17.
9
The Hallmarks of Liver Fluke Related Cholangiocarcinoma: Insight into Drug Target Possibility.
Recent Results Cancer Res. 2023;219:53-90. doi: 10.1007/978-3-031-35166-2_4.

引用本文的文献

3
SEOM-GEMCAD-TTD clinical guidelines for biliary tract cancer (2025).
Clin Transl Oncol. 2025 May 30. doi: 10.1007/s12094-025-03916-y.
4
Epigenetic regulation of individual components of combined hepatocellular-cholangiocarcinoma.
PLoS One. 2025 May 27;20(5):e0324145. doi: 10.1371/journal.pone.0324145. eCollection 2025.
5
Treating intrahepatic cholangiocarcinoma with pemigatinib: two case reports of Nordic patients.
Acta Oncol. 2025 Apr 15;64:534-539. doi: 10.2340/1651-226X.2025.42073.
6
Recent 5‑year trends in biliary tract cancer survival rates: An analytical big data survey.
Med Int (Lond). 2025 Jan 10;5(2):15. doi: 10.3892/mi.2025.214. eCollection 2025 Mar-Apr.

本文引用的文献

1
Molecular Pathogenesis of Cholangiocarcinoma.
BMC Cancer. 2019 Feb 28;19(1):185. doi: 10.1186/s12885-019-5391-0.
2
Current Practice of Hepatocellular Carcinoma Surveillance.
Acta Med Indones. 2018 Oct;50(4):353-360.
4
CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis.
J Surg Oncol. 2018 Sep;118(4):664-674. doi: 10.1002/jso.25192. Epub 2018 Sep 9.
5
Intrahepatic cholangiocarcinoma surgery: the impact of lymphadenectomy.
Chin Clin Oncol. 2018 Oct;7(5):53. doi: 10.21037/cco.2018.07.02. Epub 2018 Jul 17.
6
A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
Oncol Rep. 2018 Sep;40(3):1422-1434. doi: 10.3892/or.2018.6534. Epub 2018 Jun 27.
7
Ultrasound surveillance for cholangiocarcinoma in an endemic area: A prove of survival benefits.
J Gastroenterol Hepatol. 2018 Jul;33(7):1383-1388. doi: 10.1111/jgh.14074.
9
Current status of liver transplantation for cholangiocarcinoma.
Liver Transpl. 2018 Feb;24(2):294-303. doi: 10.1002/lt.24955.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验